Announcement on Appointment of Deputy General Manager
Filed with SSE · · 2 pages · Chinese
Jiangsu Kanion Pharmaceutical Co. Ltd. on 6ix
Earlier from Jiangsu Kanion Pharmaceutical
- Announcement on Receiving the Clinical Trial Approval Notice for Heihuang Chizhu Granules
- Announcement on the Receipt of the Clinical Trial Approval Notice for Yunpi Huatan Tongqiao Granules
- Announcement on the Receipt of the Clinical Trial Approval Notice for Plantago Seed Tablets
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Obtaining the Drug Registration Certificate for Xiebai San Granules
Later from Jiangsu Kanion Pharmaceutical
- Announcement on Receiving the Clinical Trial Approval Notice for Qingshen Tongluo Granules
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Report for Q1 2026
- Notice on Convening the 2025 Annual General Meeting
Follow Jiangsu Kanion Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Kanion Pharmaceutical